<DOC>
	<DOCNO>NCT01200875</DOCNO>
	<brief_summary>Platelet-Rich Plasma ( PRP ) ban competitive athlete people think may enhance athletic performance . However , little publish research support undermine point view . The purpose study : ( 1 ) To assess effect local platelet-rich plasma ( PRP ) therapy systemic level growth factor suspect know performance-enhancing effect ; ( 2 ) To understand whether effect PRP therapy growth factor differs intramuscular intratendinous PRP injection . This research study look 40 people receive platelet-rich plasma therapy tendon muscle injury . The study involve collect seven blood sample ( 2 teaspoon ) patient , PRP treatment . Blood sample may donate location patient 's choosing , participant pay time .</brief_summary>
	<brief_title>Performance-Enhancing Effects Platelet-Rich Plasma ( PRP ) Injections</brief_title>
	<detailed_description>To understand short-term systemic effect local PRP injection , measure serum concentration six growth factor four day follow PRP injection : human growth hormone ( hGH ) , IGF-1 , basic FGF , PDGF-BB , VEGF , IGFBP-3 . These molecule particular interest may stimulatory effect enhance athletic performance , ban competitive athlete World Anti-Doping Agency ( WADA ) . We aim recruit 40 patient receive ultrasound-guided intratendinous ( IT ) intramuscular ( IM ) PRP injection . Blood drawn immediately ( baseline ) ; 15 minute ; 3 , 24 , 48 , 72 96 hour receive PRP therapy . A fraction therapeutic PRP preparation isolate growth factor analysis . Serum concentration growth factor quantify ELISA . Statistical analysis conduct assess change growth factor follow PRP injection . To understand impact injection site systemic growth factor , change concentration also compare intratendinous intramuscular group . Study subject participate following step : ( 1 ) Initial diagnostic visit Orthopaedic Surgeon , ( 2 ) Blood collection part PRP therapy , ( 3 ) Ultrasound-guided PRP therapy administer Stanford radiologist , ( 4 ) Blood collection study . Steps ( 1 ) ( 3 ) part standard care , patient choose independently study . In step ( 4 ) , blood sample collect venipuncture various time point assayed growth factor concentration . Less 10 mL ( 2 teaspoon ) blood collect seven time point five consecutive day . In order minimize inconvenience patient meet patient location choosing , patient 's home office , blood collection day 2-5 . Participants compensate seven blood sample donate .</detailed_description>
	<mesh_term>Tendinopathy</mesh_term>
	<mesh_term>Rheumatic Diseases</mesh_term>
	<mesh_term>Collagen Diseases</mesh_term>
	<mesh_term>Performance-Enhancing Substances</mesh_term>
	<criteria>Male female patient 1850 year old , receive ultrasoundguided intratendinous intramuscular PRP injection History cancer , diabetes , hormonereplacement therapy , abnormal nutritional habit . Contraindications PRP therapy : preexisting coagulation defect include thrombocytopenia hypofibrinogenemia anticoagulation medication hypersensitivity bovine product , may use platelet activation .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>PRP</keyword>
	<keyword>platelet rich plasma</keyword>
	<keyword>platelet</keyword>
	<keyword>growth hormone</keyword>
	<keyword>tendonitis</keyword>
	<keyword>tendinosis</keyword>
	<keyword>tendinopathy</keyword>
	<keyword>enthesopathy</keyword>
	<keyword>muscle</keyword>
	<keyword>sport</keyword>
	<keyword>tendon</keyword>
</DOC>